The Scientist

» generics and developmental biology

Most Recent

image: Leaving an Imprint

Leaving an Imprint

By | August 1, 2015

Among the first to discover epigenetic reprogramming during mammalian development, Wolf Reik has been studying the dynamics of the epigenome for 30 years.

1 Comment

image: Mimicry Muses

Mimicry Muses

By | August 1, 2015

The animal world is full of clever solutions to bioengineering challenges.

0 Comments

image: Mr. Epigenetics

Mr. Epigenetics

By | August 1, 2015

Meet Wolf Reik, August Profilee and Babraham Institute director of research.

0 Comments

image: Rethinking Lymphatic Development

Rethinking Lymphatic Development

By | August 1, 2015

Four studies identify alternative origins for cells of the developing lymphatic system, challenging the long-standing view that they all come from veins.

1 Comment

image: The Prescient Placenta

The Prescient Placenta

By | August 1, 2015

The maternal-fetal interface plays important roles in the health of both mother and baby, even after birth.

1 Comment

image: Teva Buys Allergan Generics for $40.5 Billion

Teva Buys Allergan Generics for $40.5 Billion

By | July 27, 2015

Meanwhile, Allergan acquires drug developer Naurex in a $560 million deal. 

0 Comments

image: Sperm From Ovaries

Sperm From Ovaries

By | June 11, 2015

With the deletion of a single gene, female Japanese rice fish can produce sperm. 

1 Comment

image: Endo to Pay $8 Billion for Par

Endo to Pay $8 Billion for Par

By | May 19, 2015

The deal would create one of the five biggest generic drugmakers in the U.S.

0 Comments

image: Dino Snouts from Chicken Beaks

Dino Snouts from Chicken Beaks

By | May 13, 2015

Researchers tweak gene expression in chicken embryos that may have been crucial to the evolutionary transition from dinosaur noses to bird bills.

0 Comments

image: Drugmaker Teva Bids $40 Billion for Mylan

Drugmaker Teva Bids $40 Billion for Mylan

By | April 23, 2015

The Israel-based pharmaceutical company makes an unsolicited offer for a smaller, Netherlands-based rival as its main product faces competition from generics.

0 Comments

Popular Now

  1. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  2. Athletes’ Microbiomes Differ from Nonathletes
  3. Mutation Linked to Longer Life Span in Men
  4. Immune Cells Deliver Cancer Drugs to the Brain
AAAS